Evan Lippman

EVP, Business Development · 2 filings · Latest: May 14, 2026

TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
TEVA	Evan Lippman	EVP, Business Development	May 14, 2026	Sale	$35.58	41,658	$1.5M	44,191	May 18 8:02 PM
TEVA	Evan Lippman	EVP, Business Development	May 14, 2026	Option Exercise	—	85,849	—	80,103	May 18 8:02 PM